Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk confident of amycretin obesity drug launch this decade
Reuters
Fri, 03/8/24 - 11:09 am
Tags:
Novo Nordisk, amycretin, weight loss, obesity
Launches and prices of Novo Nordisk's weight-loss drug Wegovy
Reuters
Fri, 03/8/24 - 10:59 am
Tags:
Novo Nordisk, drug launches, Wegovy, drug pricing, weight loss
Novo valuation surpasses Tesla on experimental obesity drug data
Reuters
Thu, 03/7/24 - 11:40 am
Tags:
Novo Nordisk, obesity, weight loss, clinical trials, amycretin
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Tags:
Novo Nordisk, Ozempic, clinical trials, diabetes, chronic kidney disease
Novo Nordisk's new Boston-area campus reflects 'competitive' R&D growth, and not just for GLP-1s
Fierce Biotech
Thu, 02/29/24 - 11:16 am
Tags:
Novo Nordisk, Boston, R&D, Massachusetts
Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact
Medical Marketing and Media
Mon, 02/26/24 - 05:18 pm
Tags:
Novo Nordisk, molecular glue degraders, Neomorph, R&D
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
Tags:
obesity, weight loss, GLP-1 agonist, Novo Nordisk, Eli Lilly
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
Tags:
earnings, Novo Nordisk, Eli Lilly, obesity
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Tags:
Novo Nordisk, Novartis, JNJ, Bristol Myers Squibb, legal, Inflation Reduction Act, drug pricing
Actually Wegovy is good for dialysis companies, dialysis provider says
Stat
Wed, 02/21/24 - 11:12 am
Tags:
Wegovy, Novo Nordisk, dialysis, Fresenius Medical Care
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
BioSpace
Tue, 02/20/24 - 05:55 pm
Tags:
market cap, Eli Lilly, JNJ, Novo Nordisk
Novo Nordisk and Catalent deal: net positive or negative for industry?
Biopharma Reporter
Tue, 02/20/24 - 11:06 am
Tags:
Novo Nordisk, Catalent, M&A, Wegovy, Ozempic
Wegovy fuels sharp rise in use of weight-loss drugs for US youth
Reuters
Thu, 02/15/24 - 07:24 pm
Tags:
Wegovy, Novo Nordisk, pediatric
Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice
Quartz
Thu, 02/15/24 - 07:20 pm
Tags:
Novo Nordisk, Lars Fruergaard Jorgensen, Ozempic, Wegovy, weight loss
3 questions hanging over the Novo-Catalent deal
Pharma Voice
Wed, 02/14/24 - 10:55 am
Tags:
Novo Nordisk, Catalent, drug manufacturing, Ozempic Wegovy, Eli Lilly
Novo Nordisk's controlling shareholder plans to invest about $35 bln by 2030
Reuters
Mon, 02/12/24 - 11:19 pm
Tags:
Novo Nordisk, Novo Holdings
Weight-loss drugs tied to benefit after hip replacement
Reuters
Mon, 02/12/24 - 10:26 am
Tags:
hip replacements, GLP-1 agonist, Ozempic, Novo Nordisk
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
Tags:
earnings, COVID-19, GLP-1 agonist, JNJ, Bristol Myers Squibb, Pfizer, AstraZeneca, Sanofi, Eli Lilly, Novo Nordisk
As Catalent prepares to join Novo family, CDMO's sales continue to slide
Fierce Pharma
Fri, 02/9/24 - 11:21 am
Tags:
Catalent, CDMOs, earnings, Novo Nordisk
New weight-loss drugs linked to lower risk of depression: study
Axios
Fri, 02/9/24 - 11:12 am
Tags:
depression, weight loss, Novo Nordisk, Eli Lilly, Ozempic, Wegovy, Mounjaro

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.